Machine learning detects SARS-CoV-2 and variants rapidly on DNA aptamer metasurfaces
Preprint
Abstract
COVID-19 is detected using reverse transcription polymerase chain reaction (RT-PCR) of nasal swabs. A very sensitive and rapid detection technique using easily-collected fluids like saliva must be developed for safe and precise mass testing. Here, we introduce a metasurface platform for direct sensing of COVID-19 from unprocessed saliva. We computationally screen gold metasurfaces out of a pattern space of 2 100 combinations for strongly-enhanced light-virus interaction with machine learning and use it to investigate the presence and concentration of the SARS-CoV-2. We use machine learning to identify the virus from Raman spectra with 95.2% sensitivity and specificity on 36 PCR positive and 33 negative clinical samples and to distinguish wild-type, alpha, and beta variants. Our results could pave the way for effective, safe and quantitative preventive screening and identification of variants.Keywords
All Related Versions
- Published version: Advanced Devices & Instrumentation, 4.
This publication has 42 references indexed in Scilit:
- Increasing threats from SARS-CoV-2 variants: Time to establish global surveillanceScience Translational Medicine, 2021
- COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testingeClinicalMedicine, 2021
- Rapid single-molecule detection of COVID-19 and MERS antigens via nanobody-functionalized organic electrochemical transistorsNature Biomedical Engineering, 2021
- Diagnostics for SARS-CoV-2 infectionsNature Materials, 2021
- Rapid coronavirus tests: a guide for the perplexedNature, 2021
- Cerebrospinal Fluid Leak After Nasal Swab Testing for Coronavirus Disease 2019JAMA Otolaryngology–Head & Neck Surgery, 2020
- Prevalence of Asymptomatic SARS-CoV-2 InfectionAnnals of Internal Medicine, 2020
- The COVID-19 XPRIZE and the need for scalable, fast, and widespread testingNature Biotechnology, 2020
- COVID-19 diagnostics in contextScience Translational Medicine, 2020
- A rapid and label-free platform for virus capture and identification from clinical samplesProceedings of the National Academy of Sciences, 2019